From: PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury
Variable
Pearson Correlation
P value
Weekly PBA episode rate change
0.21
<.001
QOL-VAS change
0.40
PGI-C
0.47
CGI-C
0.48
PHQ-9 change
0.32
Patient satisfaction score
−0.22
MMSE change
0.01
.877